Jaw Surgery (Orthognathic Surgery) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Orthognathic surgery — commonly called jaw surgery — is a category of surgical procedures performed by oral and maxillofacial surgeons to correct skeletal and dental irregularities of the jaws and face that cannot be adequately resolved with orthodontic treatment alone. The word derives from the Greek orthos (straight) and gnathos (jaw). More than 300,000 orthognathic procedures are performed worldwide each year.

The three core operations are the Le Fort I osteotomy (repositioning of the upper jaw/maxilla in three dimensions), the bilateral sagittal split osteotomy (BSSO) (repositioning of the lower jaw/mandible), and genioplasty (chin repositioning). Surgery may involve a single jaw (single-jaw) or both jaws simultaneously (bimaxillary surgery), depending on the nature and severity of the skeletal discrepancy.

Modern orthognathic surgery is guided by virtual surgical planning (VSP) — a technology combining CBCT (cone beam CT) data, digital dental scans, and computer-aided design to simulate the surgical outcome in three dimensions before the patient enters the operating theatre. VSP-derived surgical splints (occlusal wafers) and custom cutting guides are 3D-printed, improving precision and reproducibility while reducing operating time by 20–40 minutes per jaw compared with traditional model surgery.

Jaw surgery is a collaborative undertaking between the oral and maxillofacial surgeon and an orthodontist. Orthodontic preparation — decompensating the teeth so they align to the skeletal movements planned — typically requires 12–18 months before surgery and is followed by 6–12 months of post-operative orthodontic finishing. The complete treatment journey from start to debanding averages 18–30 months. Procedures are performed under general anaesthesia; hospital admission is usually 1–3 days.

Orthognathic surgery addresses skeletal jaw discrepancies that cause functional and/or aesthetic problems. The most common indications include:

• Class II malocclusion (retrognathic mandible): The lower jaw is set back relative to the upper, creating a deep overbite and characteristic facial profile. BSSO advancement corrects mandibular retrusion; bimaxillary surgery is used when maxillary excess co-exists.
• Class III malocclusion (prognathic mandible or maxillary retrusion): The lower jaw protrudes beyond the upper, resulting in an underbite. Surgical correction involves BSSO setback, Le Fort I advancement, or a combination.
• Anterior or posterior open bite: Failure of the upper and lower teeth to contact; often requires multi-jaw surgery including differential Le Fort I impaction.
• Crossbite and facial asymmetry: Lateral discrepancies between the upper and lower jaws treated with asymmetric osteotomies.
• Obstructive sleep apnea (OSA): Maxillomandibular advancement (MMA) — simultaneous Le Fort I and BSSO advancement of ≥10 mm — is a highly effective surgical treatment for moderate-to-severe OSA, achieving a mean Apnoea-Hypopnoea Index (AHI) reduction of 50–80% in published series, comparable to or exceeding long-term CPAP adherence outcomes.
• Temporomandibular joint (TMJ) disorders: Skeletal open bite and Class II malocclusion are associated with condylar resorption and internal derangement; correcting the skeletal anatomy reduces joint loading and can reduce pain.
• Cleft lip and palate sequelae: Secondary Le Fort I advancement addresses midface retrusion after primary cleft repair.

Patient selection for orthognathic surgery is based on skeletal maturity, severity of discrepancy, functional impact, and overall medical fitness. Key eligibility criteria include:

• Completed skeletal growth: Surgery is deferred until facial growth is substantially complete — generally age 16–18 years for females and 18–21 years for males, confirmed by serial cephalometric radiographs showing no skeletal change over 12 months. Exceptions include severe sleep apnea in younger patients or distraction osteogenesis in growing children with craniofacial syndromes.
• Skeletal discrepancy not correctable by orthodontics alone: ANB angle discrepancy >5°, or significant vertical skeletal deformity (e.g., posterior facial height ratio <0.55 or >0.70) that cannot be camouflaged without dental compensation beyond biological limits.
• Significant functional impairment: Difficulty chewing, speech articulation problems, airway compromise, TMJ pain, or chronic headaches attributable to the jaw discrepancy.
• Pre-operative orthodontic assessment: A detailed orthodontic treatment plan must be in place. Teeth are decompensated (aligned to the skeletal bases) before surgery, which may temporarily worsen the bite in the preparation phase — patients must be counselled on this.
• Medical fitness for general anaesthesia: Standard pre-operative assessment including cardiorespiratory evaluation, full blood count, coagulation screen. If OSA is suspected, a pre-operative sleep study (polysomnography or oximetry) is recommended.
• Contraindications: Active periodontal disease (must be treated first), uncontrolled systemic illness, psychological unreadiness, unrealistic aesthetic expectations, and active condylar growth (risk of relapse).

The specific operation is tailored to each patient's anatomy and functional goals. The main procedures are:

• Le Fort I osteotomy: A horizontal cut through the maxilla above the tooth roots allows the entire upper jaw — including the teeth and hard palate — to be repositioned in any plane (up, down, forward, back, rotated). It is the workhorse for correcting vertical excess or deficiency, retrusion, and asymmetry. Blood supply is maintained via the pterygo-maxillary vascular pedicle.
• Bilateral sagittal split osteotomy (BSSO): First described by Trauner and Obwegeser (1957), modified by Dal Pont (1961), and the Hunsuck modification — this split divides the mandibular ramus between the medial and lateral cortices, allowing the tooth-bearing segment to be advanced or set back. Rigid fixation with titanium plates and screws maintains the new position.
• Genioplasty: A horizontal cut in the chin bone (symphysis) allows repositioning — advancement, setback, vertical reduction or increase, or correction of asymmetry. Often performed in conjunction with BSSO for comprehensive profile correction.
• Bimaxillary surgery: Simultaneous Le Fort I and BSSO; addresses complex three-dimensional discrepancies more precisely than single-jaw surgery; required for OSA correction (MMA). Operating time is typically 3–5 hours.
• Virtual surgical planning (VSP): VSP (e.g., ProPlan CMF, IPS CaseDesigner) merges CBCT with optical dental scans. The surgeon simulates the osteotomies, skeletal movements, and resultant occlusion on screen before committing to surgery. 3D-printed wafers guide jaw position intraoperatively. VSP adds approximately $1,500–$3,000 to procedure costs but reduces errors significantly.
• Total jaw reconstruction: For oncologic defects, severe congenital anomalies, or failed prior alloplastic implants — custom titanium jaw prostheses (CAD/CAM) or free fibula flaps may replace entire jaw segments.

When appropriately indicated and combined with orthodontic treatment, jaw surgery delivers measurable improvements across functional, aesthetic, and quality-of-life domains:

• Improved bite function: Correction of malocclusion enables efficient bilateral chewing, reduces asymmetric loading of the TMJ, and can resolve chronic headaches and neck pain associated with jaw malalignment.
• Obstructive sleep apnea resolution: Maxillomandibular advancement is one of the most effective permanent treatments for OSA. Published meta-analyses report mean AHI reduction from ~55 events/hour to ~10 events/hour post-MMA — a surgical cure rate (AHI <5) of ~50–60% in optimally selected patients.
• Speech improvement: Open bite and Class III malocclusion impair sibilant and fricative consonant production. Surgical correction normalises tongue-to-palate contact and speech articulation.
• Facial aesthetics and psychological wellbeing: Systematic reviews consistently demonstrate significant improvements in self-reported psychosocial function, body image, and quality of life scores (OQLQ, SF-36) following orthognathic surgery, with benefits maintained at 5-year follow-up.
• TMJ decompression: Correcting Class II skeletal relationships redistributes condylar loads, reducing TMJ pain and joint effusion in susceptible patients.
• Long-term skeletal stability: Properly planned and executed orthognathic surgery combined with adequate post-operative retention achieves stable results in the majority of patients; Le Fort I impaction and BSSO advancement are among the most stable movements.

Orthognathic surgery carries a well-defined risk profile that should be discussed thoroughly during the consent process:

• Inferior alveolar nerve (IAN) paresthesia: Temporary numbness or altered sensation of the lower lip and chin is reported in 30–50% of BSSO patients; the majority resolves within 6–12 months. Permanent paresthesia occurs in fewer than 5% of cases and is technique-dependent.
• Skeletal relapse: Some degree of post-surgical movement occurs as soft tissue forces adapt to the new skeletal position. Clinically significant relapse (requiring re-operation) occurs in 5–15% of cases; large mandibular advancements (>10 mm) and inferior repositioning of the maxilla carry higher relapse risk.
• Infection: Surgical site infection and hardware infection occur in approximately 1–3% of cases; risk is reduced by peri-operative antibiotics (amoxicillin/clavulanate) and meticulous oral hygiene.
• Titanium hardware complications: Plate and screw removal is required in approximately 10% of cases due to plate palpability, infection, or cold sensitivity; this is a minor secondary procedure under local anaesthesia.
• Condylar resorption: Progressive post-surgical resorption of the mandibular condyle affects approximately 3–10% of Class II female patients; risk factors include pre-existing TMJ disease, open bite, and large BSSO advancements.
• Airway oedema: Upper airway swelling in the immediate post-operative period mandates monitoring; prophylactic dexamethasone is standard. Rarely, temporary nasopharyngeal airway support is required.
• Haemorrhage: Significant intraoperative haemorrhage occurs in <1% of cases. Le Fort I descending palatine artery and pterygoid venous plexus are at risk.
• Unfavourable occlusion: Despite VSP, minor occlusal discrepancies requiring additional post-operative orthodontics occur in a minority of patients.

Recovery from orthognathic surgery follows a predictable timeline, with patients requiring significant support during the first 2–6 weeks:

• Immediate post-operative period (0–2 weeks): Hospital stay 1–3 days; significant facial oedema peaks at 48–72 hours and resolves over 3–6 weeks; nasal congestion is expected after Le Fort I; a liquid diet (soups, smoothies, protein shakes) is maintained for 2 weeks; oral hygiene with chlorhexidine rinse; pain management with paracetamol and oral NSAIDs.
• Intermediate recovery (2–6 weeks): Progression to soft/mashed diet (soft pasta, mashed potato, scrambled eggs) from week 2; maxillomandibular fixation (MMF) with elastic guidance may be applied for 2–6 weeks in some surgical plans; jaw exercises for range of motion as instructed by the surgeon.
• Return to normal activity: Light activity from week 2; return to desk work at 2–3 weeks; no contact sports or strenuous exercise for 6–8 weeks; return to a normal diet typically at 6–8 weeks after bimaxillary surgery.
• Post-operative orthodontics: Orthodontic finishing — detailing the occlusion — commences approximately 6 weeks after surgery and lasts a further 6–12 months; retainers are fitted on orthodontic debanding.
• Imaging and stability assessment: CBCT at 3 months and 12 months documents skeletal position and condylar morphology; cephalometric analysis confirms planned movements were achieved.
• Post-MMA sleep assessment: A repeat sleep study (polysomnography) is recommended 3–6 months post-MMA to quantify AHI reduction and determine whether CPAP can be discontinued.

The total cost of orthognathic surgery treatment encompasses surgical fees, anaesthesia, hospital stay, pre-operative imaging and VSP, and orthodontic fees — each of which varies by geography and provider:

• United States: Single-jaw surgery (BSSO or Le Fort I alone): $20,000–$35,000; bimaxillary surgery: $35,000–$55,000; genioplasty add-on: $3,000–$6,000; VSP planning: $1,500–$3,000 additional; orthodontics: $3,000–$8,000 (pre- and post-operative combined).
• United Kingdom: NHS coverage is available for cases meeting medical necessity criteria (functional impairment); private surgery ranges from £8,000–£20,000 for single-jaw to £18,000–£35,000 for bimaxillary.
• India: Bimaxillary surgery at accredited centres: ₹2,00,000–₹6,00,000 ($3,000–$8,000 USD); includes high-quality CBCT and surgical planning at top institutions (AIIMS, Apollo, Manipal).
• Thailand and Malaysia: Bimaxillary surgery: $5,000–$12,000 USD at JCI-accredited hospitals (Bumrungrad, Bangkok Hospital, Prince Court Medical Centre).
• Insurance: Coverage varies significantly. In the US, insurance typically covers surgery classified as medically necessary (functional impairment) but may exclude purely aesthetic cases; a detailed 'letter of medical necessity' from the surgeon and orthodontist is required. Pre-authorisation is essential.

Depending on the severity of the skeletal discrepancy and the patient's goals, several non-surgical or less invasive alternatives may be considered:

• Orthodontic camouflage: In mild skeletal discrepancies (ANB discrepancy 2–5°), orthodontic treatment alone — including extractions to create space for dental compensation — can produce acceptable occlusion without altering the underlying bony structure. However, camouflage has biomechanical limits and may compromise facial aesthetics in moderate-to-severe cases.
• Functional/orthopaedic appliances (growing patients): Devices such as twin-block, Herbst appliance, and Frankel appliance can redirect jaw growth in pubertal patients and reduce the magnitude of surgical correction required.
• Clear aligner therapy (Invisalign, ClearCorrect): Suitable for mild cases; increasingly capable of managing dental compensations, but cannot address skeletal jaw discrepancies.
• CPAP and mandibular advancement devices for OSA: Non-surgical alternatives for obstructive sleep apnea; CPAP is highly effective but requires nightly compliance; mandibular advancement devices (MADs) are effective for mild-moderate OSA but do not address the skeletal basis of the obstruction.
• Distraction osteogenesis: Gradual skeletal expansion using an internal or external distractor device; preferred for very large mandibular deficiencies or in growing patients with severe problems; avoids the relapse risk associated with acute large advancements.
• Alloplastic implants: Custom chin and malar (cheek) implants can address limited aesthetic concerns related to chin deficiency or facial profile but do not correct the malocclusion.